Advance in piperazine-containing compounds as receptor ligands

Chinese Pharmaceutical Journal

Volumn 44, Issue 18, 2009, Pages 1361-1368

  Gan, Lin Ling ^a   Cai, Jia Li ^a   Zhou, Cheng He ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

3 [[4 (4 CHLOROPHENYL) 1 PIPERAZINYL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE; ARIPIPRAZOLE; BP 897; BUSPIRONE; CLOZAPINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; FLUPHENAZINE; GEPIRONE; IPSAPIRONE; LOXAPINE; MELANOCORTIN 4 RECEPTOR; OLANZAPINE; PEROSPIRONE; PERPHENAZINE; PIPERAZINE DERIVATIVE; PRAZOSIN; QUETIAPINE; RISPERIDONE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SUNEPITRON; TANDOSPIRONE; TRIFLUOPERAZINE; TRIMAZOSIN; UNINDEXED DRUG; URAPIDIL; ZALOSPIRONE; ZIPRASIDONE;

ARTICLE; ATTENTION DEFICIT DISORDER; CACHEXIA; CELL STRAIN HEK293; DRUG RECEPTOR BINDING; DRUG STRUCTURE; HUMAN; HUMAN CELL; IRRITABLE COLON; SCHIZOPHRENIA; STRUCTURE ACTIVITY RELATION; TRANQUILIZING ACTIVITY;

EID: 70350136471     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. CHEN R H, GUO Y, LIU T G. Review on piperazines as calcium channel blocker[J]. China Pharm, 2006, 17 (2) : 142-144.
2. 1A) receptors[J]. Arch Pharm Chem Life Sci, 2007, 340 (9) : 456-465.
3. 3 receptor ligands: potential substance abuse therapeutic agents[J]. J Med Chem, 2007, 50 (17) : 4135-4146.
4. 1A receptor affinity, exhibits antipsychotic properties in animal models of schizophrenia[J]. Pharmacol Biochem Behav, 2005, 82 (2) : 361-372.
5. 3 receptor agents with N-[4-(4-arylpiperazin-1-yl)butyl]-arylcarboxamide structure[J]. J Med Chem, 2005, 48 (25) :7919-7922.
6. 3-preferring agonist with potent in vivo activity with long duration of action[J]. J Med Chem, 2008, 51 (1) : 101-117.
7. 4 receptor agonists for the treatment of erectile dysfunction[J]. J Med Chem, 2006, 49 (17) : 5093-5109.
8. 4 partial agonist[J]. J Med Chem, 2006, 49 (13) : 3938-3947.
9. 1A agonist (PRX-00023) for the treatment of anxiety and depression [J]. J Med Chem, 2006, 49 (11) : 3116-3135.
10. 1A receptor ligands containing a norbornene nucleus: synthesis and in vitro pharmacological evaluation [J]. J Med Chem, 2005, 48 (17) : 5495-5503.
11. 1-adrenoceptor antagonists[J]. Bioorg Med Chem Lett, 2005, 15 (13) : 3216-3219.
12. 1-adrenoceptor antagonists[J]. Chin J Med Chem, 2006, 16 (6) : 336-341.
13. TODOROVIC A, HASKELL-LUEVANO C. A review of melanocortin receptor small molecule ligands[J]. Peptides, 2005, 26 (10) : 2026-2036.
14. FOTSCH C, HAN N, ARASASINGHAM P, et al. Melanocortin subtype-4 receptor agonists containing a piperazine core with substituted aryl sulfonamides[J]. Bioorg Med Chem Lett, 2005, 15 (6) : 1623-1627.
15. PALUCKI B, PARK M K, NARGUND R P, et al. 2-Piperazinecarboxamides as potent and selective melanocortin subtype-4 receptor agonists[J]. Bioorg Med Chem Lett, 2005, 15(8): 1993-1996.
16. CHEN C, TUCCI F C, JIANG W L, et al. Pharmacological and pharmacokinetic characterization of 2-piperazine-α-isopropyl benzylamine derivatives as melanocortin-4 receptor antagonists[J]. Bioorg Med Chem, 2008, 16 (10) : 5606-5618.
17. NOZAWA D, OKUBO T, ISHII T, et al. Novel piperazines: Potent melanocortin-4 receptor antagonists with anxiolytic-like activity[J]. Bioorg Med Chem, 2007, 15 (5) :2375-2385. (Pubitemid 46240913)
18. NOZAWA D, OKUBO T, ISHII T, et al. Structure-activity relationships of novel piperazines as antagonists for the melanocortin-4 receptor[J]. Bioorg Med Chem, 2007, 15 (5) : 1989-2005. (Pubitemid 46176631)
19. 2 receptors[J]. Bioorg Med Chem, 2008, 16 (2) : 755-761. (Pubitemid 351163058)
20. WEIGL M, WÜNSCH B. Synthesis of bridged piperazines with σ receptor affinity[J]. Eur J Med Chem, 2007, 42 (10) : 1247-1262.
21. 2 activity[J]. J Med Chem, 2004, 47 (12) : 2308-2317.
22. 7 receptor [J]. Bioorg Med Chem Lett, 2008, 18 (2) : 571-575.
23. 7 antagonists[J]. Bioorg Med Chem Lett, 2008, 18 (6) : 2093-2096.
24. 7 antagonists[J]. Bioorg Med Chem Lett, 2008, 18 (14) : 3848-3851.
25. GIBSON H E, EDWARDS J G, PAGE R S, et al. TRPV1 channels mediate long-term depression at synapses on hippocampal interneurons[J]. Neuron, 2008, 57 (5) : 746-759.
26. SWANSON D M, DUBIN A E, SHAH C, et al. Identification and biological evaluation of 4-(3-trifluoromethylpyridin-2-yl) piper azine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl) amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonist[J]. J Med Chem, 2005, 48 (6) : 1857-1872.
27. SHAO B, HUANG J C, SUN Q, et al. 4-(2-Pyridyl)piperazine-1-benzimidazoles as potent TRPV1 antagonists[J]. Bioorg Med Chem Lett, 2005, 15 (3) : 719-723.
28. OGNYANOV V I, BALAN C, BANNON A W, et al. Design of potent, orally available antagonists of the transient receptor potential vanilloid 1. Structure-activity relationships of 2-piperazin-1-yl-1H-benzimid-azoles[J]. J Med Chem, 2006, 49 (12) : 3719-3742. (Pubitemid 43902478)
29. WANG H L, KATON J, BALAN C, et al. Novel vanilloid receptor-1 antagonists: 3. the identification of a second-generation clinical candidate with improved physicochemical and pharmacokinetic properties[J]. J Med Chem, 2007, 50 (15) : 3528-3539.
30. 3 receptor ligands[J]. Chin Pharm J, 2007, 46 (6) : 404-409.
31. 3 antagonists and serotonin reuptake inhibitors[J]. Bioorg Med Chem Lett, 2008, 18 (1) : 39-43.
32. HOOGENBAND A, MAARSEVEEN J H, MCCREARY A C, et al. Piperazinyl oxime ethers as NK-1 receptor antagonists[J]. Bioorg Med Chem Lett, 2006, 16 (4) : 1045-1048.
33. 3 receptor antagonists II [J]. Bioorg Med Chem Lett, 2006, 16 (22) : 5752-5756. (Pubitemid 44508824)
34. TAKAHASHI T, SAKURABA A, HIROHASHI T, et al. Novel potent neuropeptide Y Y5 receptor antagonists: synthesis and structure-activity relationships of phenylpiperazine derivatives[J]. Bioorg Med Chem, 2006, 14 (22) : 7501-7511.
35. SONG K S, LEE S H, CHUN H J, et al. Design, synthesis and biological evaluation of piperazine analogues as CB1 cannabinoid receptor ligands[J]. Bioorg Med Chem, 2008, 16 (7) : 4035-4051.
36. ARNOUND J C, DELOUVRIÉ B, BOUTRON P, et al. Synthesis and structure-activity relationships of thieno[2,3-b]pyrroles as antagonists of the GnRH receptor[J]. Bioorg Med Chem Lett, 2007, 17 (23) : 6448-6454.